Researchers at the University of Guelph have unlocked the process of manufacturing two pain-relieving molecules in cannabis that are said to be nearly 30 times more powerful than aspirin.

The study, published in the August 2019 volume of Phytochemistry, had professors Tariq Akhtar and Steven Rothstein use biochemistry and genomics to determine how cannabis makes the molecules called cannflavin A and cannflavin B.

Known as ‘flavonoids,’ cannflavins A and B were first identified in 1985, “when research verified they provided anti-inflammatory benefits that were nearly 30 times more effective…than aspirin” the university said in a press release.

– Read the entire article at CTV News.